Yang Xi

690 total citations
22 papers, 543 citations indexed

About

Yang Xi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yang Xi has authored 22 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yang Xi's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (5 papers) and Gut microbiota and health (5 papers). Yang Xi is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (5 papers) and Gut microbiota and health (5 papers). Yang Xi collaborates with scholars based in China, United States and Russia. Yang Xi's co-authors include Shuwen Han, Qi Quan, Chun Zhang, Qiang Wei, Qing Zhou, Da Miao, Zheng Yan, Yuefen Pan, Wei Wu and Ningling Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal Of Pathology and Gene.

In The Last Decade

Yang Xi

20 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Xi China 12 401 255 88 66 44 22 543
Mohd Omar Faruk Sikder United States 7 246 0.6× 153 0.6× 68 0.8× 44 0.7× 25 0.6× 14 428
Haosheng Tang China 9 296 0.7× 129 0.5× 72 0.8× 58 0.9× 21 0.5× 9 430
Zhibo Zhao China 13 251 0.6× 147 0.6× 56 0.6× 33 0.5× 46 1.0× 25 447
Judeng Zeng China 9 275 0.7× 85 0.3× 66 0.8× 28 0.4× 36 0.8× 10 371
Giovanna C. Cavalcante Brazil 14 329 0.8× 107 0.4× 69 0.8× 40 0.6× 26 0.6× 37 539
Emad Gamil Khidr Egypt 12 245 0.6× 213 0.8× 47 0.5× 18 0.3× 49 1.1× 25 454
Chunli Liang China 10 249 0.6× 171 0.7× 36 0.4× 26 0.4× 29 0.7× 17 393
Chaewon Lee Hong Kong 5 372 0.9× 272 1.1× 46 0.5× 28 0.4× 53 1.2× 7 572
Anna Prossomariti Italy 8 182 0.5× 87 0.3× 73 0.8× 35 0.5× 41 0.9× 11 337
Lingping Kong China 16 473 1.2× 349 1.4× 88 1.0× 32 0.5× 30 0.7× 26 781

Countries citing papers authored by Yang Xi

Since Specialization
Citations

This map shows the geographic impact of Yang Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Xi more than expected).

Fields of papers citing papers by Yang Xi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Xi. The network helps show where Yang Xi may publish in the future.

Co-authorship network of co-authors of Yang Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Xi. A scholar is included among the top collaborators of Yang Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Xi. Yang Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qianqian, et al.. (2025). Long noncoding HOXD-AS1: a crucial regulator of malignancy. Frontiers in Cell and Developmental Biology. 13. 1543915–1543915.
2.
Xi, Yang, et al.. (2024). MLPH regulates EMT in pancreatic adenocarcinoma through the PI3K-AKT signaling pathway. Journal of Cancer. 15(17). 5828–5838. 1 indexed citations
3.
Chen, Jiming, Wu Yinhang, Qing Zhou, et al.. (2023). GPX3 is a key cholesterol-related gene associated with prognosis and tumor-infiltrating T cells in colorectal cancer. Neoplasma. 70(5). 645–658. 3 indexed citations
5.
Xi, Yang, Zhuang Jing, Wei Wu, et al.. (2021). Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network. BMC Cancer. 21(1). 127–127. 30 indexed citations
6.
Xi, Yang, Hong Zheng, Rong Zhang, et al.. (2021). Epigenetic Therapy Promotes the Ratio of Th1/Th17 Lineage to Reverse Immune Evasion and Treat Leukemia Relapse Post-allogeneic Stem Cell Transplantation in Non-APL AML Patients. Frontiers in Molecular Biosciences. 7. 595395–595395. 8 indexed citations
7.
Liao, Qi, Linbo Chen, Ning Zhang, et al.. (2020). Network analysis of KLF5 targets showing the potential oncogenic role of SNHG12 in colorectal cancer. Cancer Cell International. 20(1). 439–439. 10 indexed citations
8.
Xi, Yang, et al.. (2020). Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer. BMC Cancer. 20(1). 585–585. 26 indexed citations
9.
Han, Shuwen, et al.. (2020). Can small nucleolar RNA be a novel molecular target for hepatocellular carcinoma?. Gene. 733. 144384–144384. 18 indexed citations
10.
Han, Shuwen, et al.. (2020). Effects of postoperative adjuvant chemotherapy and palliative chemotherapy on the gut microbiome in colorectal cancer. Microbial Pathogenesis. 149. 104343–104343. 21 indexed citations
11.
Liu, Quan, et al.. (2019). The resistance mechanism of Escherichia coli induced by ampicillin in laboratory. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Zuo, Fei, Lijuan Yin, Yang Xi, et al.. (2019). Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer. Gut Pathogens. 11(1). 18–18. 36 indexed citations
13.
Han, Shuwen, Yang Xi, Qi Quan, et al.. (2019). Relationship Between Intestinal Microorganisms and T Lymphocytes In Colorectal Cancer. Future Oncology. 15(14). 1655–1666. 9 indexed citations
14.
Xi, Yang, et al.. (2019). Mortality in US In-Center Hemodialysis Patients Following Exposure to Wildfire Smoke PM2.5. Environmental Epidemiology. 3(Supplement 1). 448–448.
15.
Han, Shuwen, et al.. (2018). Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review. Cancer Management and Research. Volume 10. 199–206. 40 indexed citations
16.
Han, Shuwen, Yuefen Pan, Yang Xi, et al.. (2018). Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis. Cancer Biology & Therapy. 20(1). 81–89. 36 indexed citations
17.
Han, Shuwen, Qing Zhou, Zheng Yan, & Yang Xi. (2017). Competitive endogenous RNA in colorectal cancer: A systematic review. Gene. 645. 157–162. 58 indexed citations
18.
Zhang, Chun, et al.. (2017). lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma. Cancer Biomarkers. 21(3). 651–659. 119 indexed citations
19.
Watanabe, Sugiko, Yuko Hino, Yoko Sekita, et al.. (2009). HMGA1 Is Induced by Wnt/β-Catenin Pathway and Maintains Cell Proliferation in Gastric Cancer. American Journal Of Pathology. 175(4). 1675–1685. 68 indexed citations
20.
Sun, Ningling, et al.. (2007). [Plasma hydrogen sulfide and homocysteine levels in hypertensive patients with different blood pressure levels and complications].. PubMed. 35(12). 1145–8. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026